Expression of feline leukaemia virus gp85 and gag proteins and assembly into virus-like particles using the baculovirus expression vector system

References

1. Akerblom L., Stromstedt H., Osterhaus A., Morein B. 1989; Formation and characterization of FeLV ISCOMS. Faceine 7:142–147
   [Google Scholar]
2. Baltimore D. 1975; Tumor viruses. Cold Spring Harbor Symposia on Quantitative Biology 39:1187–1200
   [Google Scholar]
3. Bolognesi D. P., Montelaro R. C., Frank H., Schafer W. 1978; Assembly of type-C oncornaviruses: a model. Science 199:183–186
   [Google Scholar]
4. Cochran M. A., Erickson B. L., Knell J. D., Smith G. E. 1987; Use of baculovirus recombinants as a general method of the production of subunit vaccines. In Vaccines’ 87 pp 384–388 Edited by Chanock R. M., Lerner R. A., Brown F., Ginsberg H. New York: Cold Spring Harbor Laboratory;
   [Google Scholar]
5. Cole G. E., Stacy-Phipps S., Nunberg J. H. 1990; Recombinant feline herpesvirus expressing feline leukemia virus envelope and gag proteins. Journal of Virology 64:4930–4938
   [Google Scholar]
6. Delchambre M., Gheysen D., Thines D., Thiriat C., Jacobs E., Verdin E., Horth M., Burny A., Bex F. 1989; The gag precursor of simian immunodeficiency virus assembles into viruslike particles. EMBO Journal 8:2653–2660
   [Google Scholar]
7. de Noronha F., Schafer W., Essex M., Bolognesi D. P. 1978; Influence of antisera to oncornavirus glycoprotein (gp71) on infections of cats with feline leukemia virus. Virology 85:617–621
   [Google Scholar]
8. Donahue P. R., Hoover E. A., Beltz G. A., Riedel N., Hirsch V. M., Overbaugh J., Mullins J. I. 1988; Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. Journal of Virology 62:722–731
   [Google Scholar]
9. Gheysen D., Jacobs E., deForesta F., Thiriart C., Francotte M., Thines D., De Wilde M. 1989; Assembly and release of HIV-1 precursor pr55^9a9 virus-like particles from recombinant baculovirus infected insect cells. Cell 59:103–112
   [Google Scholar]
10. Grant C. K., Ernisse B. J., Jarrett O., Jones F. R. 1983; Feline leukemia virus envelope gp70 of subgroups B and C defined by monoclonal antibodies with cytotoxic and neutralizing functions. Journal of Immunology 131:3042–3048
    [Google Scholar]
11. Haffar O. K., Smithgall M. D., Moran P. A., Travis B. M., Zarling J. M., Hu S.-L. 1991; HIV-specific humoral and cellular immunity in rabbits vaccinated with recombinant human immunodeficiency virus-like gag-env particles. Virology 183:487–495
    [Google Scholar]
12. Henley J. P., Stewart D. C., Dickerson T. V. 1986; Evaluating the efficacy of feline leukemia vaccinations in two high-risk colonies. Veterinary Medicine 81:470–474
    [Google Scholar]
13. Hink W. F., Thomsen D. R., Meyer A. L., Davidson D. J., Castellino F. J. 1991; Expression of three recombinant proteins using baculovirus vectors in 23 insect cell lines. Biotechnology Progress 7:9–14
    [Google Scholar]
14. Holt C. A., Osorio K., Lilly F. 1986; Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities. Journal of Experimental Medicine 164:221–226
    [Google Scholar]
15. Hu S. -L., Kosowski S. G., Schaaf K. F. 1987; Expression of envelope glycoprotein of human immunodeficiency virus by an insect virus vector. Journal of Virology 61:3617–3620
    [Google Scholar]
16. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227:680–685
    [Google Scholar]
17. LaPrevotte I., Hampe A., Sherr C. J., Galibert F. 1984; Nucleotide sequence of the gag and gag-pol junction of feline leukemia virus. Journal of Virology 50:884–894
    [Google Scholar]
18. Legendre A. M., Mitchener K. L., Potgieter L. N. D. 1990; Efficacy of a feline leukaemia virus vaccine in a natural exposure challenge. Journal of Veterinary and Internal Medicine 4:92–98
    [Google Scholar]
19. Luckow V. A. 1990; Cloning and expression of heterologous genes in insect cells with baculovirus vectors. In Recombinant DNA Technology and Applications Edited by Ho C., Prokop A., Bajpai R. New York: McGraw-Hill;
    [Google Scholar]
20. Luckow V. A., Summers M. D. 1988; Trends in the development of baculovirus expression vectors. Bio/Technology 6:47–55
    [Google Scholar]
21. Luckow V. A., Summers M. D. 1989; High level expression of nonfused foreign genes with Autographa califomica nuclear polyhedrosis virus expression vector. Virology 170:31–39
    [Google Scholar]
22. Luo L., Li Y., Kang Y. 1990; Expression of gag precursor protein and secretion of virus-like particles of HIV-2 from recombinant baculovirus-infected insect cells. Virology 179:874–880
    [Google Scholar]
23. Lutz H., Bruggman S., Corbez S., Muller L., Limacher W., Weber H., Wissler K., Theilen G. H. 1981; Combination of polyacrylamide gel electrophoresis with enzyme-linked immunosorbent assay: a simple method of determination of antibody specificity and detection of antigens in complex mixtures. Veterinary Immunology and Immunopathology 2:425–440
    [Google Scholar]
24. Lutz H. 1990; Feline retroviruses: a brief review. Veterinary Microbiology 23:131–146
    [Google Scholar]
25. Lutz H., Pedersen N. C., Theilen G. H. 1983; Course of feline leukemia virus infections and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies. American Journal of Veterinary Research 44:2054–2059
    [Google Scholar]
26. Madisen L., Travis B., Hu S.-L., Purchio A. F. 1987; Expression of the human immunodeficiency virus gag gene in insect cells. Virology 158:248–250
    [Google Scholar]
27. Morikawa S., Booth T. F., Bishop D. H. L. 1991; Analyses of the requirements for the synthesis of virus-like particles by feline immunodeficiency virus gag using baculovirus vectors. Virology 183:288–297
    [Google Scholar]
28. Noteborn M. H. M., de Boer G. F., Kant A., Koch G., Bos J. L., Zantema A., Van Der Eb A. J. 1990; Expression of avian leukaemia virus ent-gp85 in Spodoptera frugiperda cells by use of a baculovirus expression vector. Journal of General Virology 71:2641–2648
    [Google Scholar]
29. Nunberg J. H., Rodgers G., Gilbert J. H., Snead R. M. 1984; Method to map antigenic determinants recognized by monoclonal antibodies: localization of a determinant of virus neutralization on the feline leukemia virus envelope protein gp70. Proceedings of the National Academy of Sciences, U.S.A. 81:3675–3679
    [Google Scholar]
30. Osterhaus A., Weuer K., Uytdehaag F., Jarrett O., Sundquist B., Morein B. 1985; Induction of protective immune response in cats by vaccination with feline leukemia virus ISCOMS. Journal of Immunology 135:591–596
    [Google Scholar]
31. Osterhaus A., Weuer K., UytdeHaag F. 1987; Comparison of serological responses in cats vaccinated with two different FeLV vaccine preparations. Veterinary Record 121:260–271
    [Google Scholar]
32. Osterhaus A., Weuer K., Uytdehaag F., Knell P., Jarrett O., Akerblom L., Morein B. 1989; Serological response in cats, vaccinated with FeLV ISCOMS and an inactivated FeLV vaccine. Vaccine 7:137–141
    [Google Scholar]
33. Overton H. A., Fujii Y., Price I. R., Jones I. M. 1989; The protease and gag gene products of the human immunodeficiency virus: authentic cleavage and post-translational modification in an insect expression system. Virology 170:107–116
    [Google Scholar]
34. Papsidero L. D., Sheu M., Ruscetti F. W. 1989; Human immunodeficiency virus type-1 neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping. Journal of Virology 63:267–272
    [Google Scholar]
35. Pollack R. V. H., Scarlett J. M. 1990; Randomized blind trail of a commercial FeLV vaccine. Journal of the American Veterinary Medical Association 196:611–616
    [Google Scholar]
36. Rasmussen L., Battles J. K., Ennis W. H., Nagashima K., Gonda M. A. 1990; Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus. Virology 178:435–451
    [Google Scholar]
37. Rojko J., Essex M., Trainin Z. 1988; Feline leukemia/sarcoma viruses and immunodeficiency. Advances in Veterinary Science and Comparative Medicine 32:57–96
    [Google Scholar]
38. Rusche J. R., Lynn D. L., Robert-Guroff M., Langlois A. L., Lyerly H. K., Carson H., Krohn K., Ranki A., Gallo R. C., Bolognesi D. P., Putney S. D., Matthews T. J. 1987; Humoral immune response to the entire human immunodeficiency virus envelope glycoprotein made in insect cells. Proceedings of the National Academy of Sciences, U.S.A. 84:6924–6928
    [Google Scholar]
39. Sharpe R. L. 1986; Evaluation of immunosuppressive effects. In Proceedings of the Symposium on Feline Leukaemia Virus Infections, Orlando, Florida pp 18–19
    [Google Scholar]
40. Summers M. D., Smith G. E. 1987; A manual of methods for baculovirus vectors and insect cell culture procedures. Texas Agricultural Experimental Station Bulletin no. 1555
    [Google Scholar]
41. Thomsen D. R., Post L. E., Elhammer A. P. 1990; Structure of O-glycosidically linked oligosaccharides synthesized by the insect cell line Sf9. Journal of Cellular Biochemistry 43:67–79
    [Google Scholar]
42. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A. 76:4350–4354
    [Google Scholar]
43. Wardley R. C., Berlinski P. J., Thomsen D. R., Meyer A. L., Post L. E. 1992; The use of feline herpesvirus and baculovirus as vaccine vectors for the gag and env genes of feline leukaemia virus. Journal of General Virology 73:1811–1818
    [Google Scholar]
44. Wells D. E., Compans R. W. 1990; Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells. Virology 176:575–586
    [Google Scholar]
45. Yoshinaka Y., Katoh I., Copeland T. D., Oroszlan S. 1985; Translational read through of an amber termination codon during synthesis of feline leukemia virus protease. Journal of Virology 55:870–873
    [Google Scholar]
46. Zelikman I., Akerblom L., Hjerten S., Morein B. 1989; Free gp70 from FeLV: enrichment from cell culture fluid by ferric oxideagarose chromatography. Biotechnology and Applied Biochemistry 11209–216
    [Google Scholar]